This inventor holds 3 USPTO granted patents. Top assignee: Fujirebio Inc.. Active years: 1993-1996.
Location History:
- Fussa, JP (1993)
- Tokyo, JP (1995 - 1996)
Company Filing History:
Years Active: 1993-1996
Title: Misao Aoyama: Innovator in Cholesterol-Lowering Agents
Introduction
Misao Aoyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering agents. With a total of 3 patents to his name, Aoyama's work has had a notable impact on health and medicine.
Latest Patents
Aoyama's latest patents include innovative 4-fluorobiphenyl derivatives. These derivatives are characterized by their strong inhibitory effect on HMG-CoA reductase, making them useful as cholesterol-lowering agents. The specific formula includes a variety of functional groups, such as a .omega.-oxycarbonyldihydroxybutyl group and halogen atoms, which enhance their effectiveness. These compounds serve not only as cholesterol-lowering agents but also as intermediates for producing related pharmaceutical products.
Career Highlights
Misao Aoyama is currently associated with Fujirebio Inc., a company known for its advancements in medical diagnostics and therapeutics. His work at Fujirebio has allowed him to focus on innovative solutions for health-related challenges, particularly in lipid management.
Collaborations
Aoyama has collaborated with notable colleagues, including Masakatsu Matsumoto and Nobuko Watanabe. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Misao Aoyama's contributions to the development of cholesterol-lowering agents highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in health and medicine.